PATENT CLAIM ANALYSIS

Application Number: 16267063
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-05
Patent Classification: ["424", "450000"]

Abstract:
The present invention relates to RNA containing compositions for use in the treatment or prophylaxis of tumor and/or cancer diseases, to a pharmaceutical composition, to a kit and to uses of the RNA containing compositions for the treatment or prophylaxis of tumor and/or cancer diseases.

Claim (Index 69):
The method of  claim 67 , wherein the checkpoint modulator therapy is selected from the group consisting of an agonistic antibody, an antagonistic antibody, a dominant negative receptor, a decoy receptor, and a ligand.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 99.0
- Lexical Diversity: 1.71429
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15136295', '15890413', '15890736', '14769720', '15995889']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8108838449931728
- 35 USC 102 Novelty (BERT): 0.6049149392825944
- Combined Prediction Score: 0.790286954422115
- Mean Citation Score: 437.741228
- Max Citation Score: 744.91895
- Similarity Product: 427.4959643698603

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test